Equities analysts expect ICU Medical, Incorporated (NASDAQ:ICUI) to announce $314.60 million in sales for the current quarter, Zacks reports. Two analysts have made estimates for ICU Medical’s earnings, with the highest sales estimate coming in at $316.70 million and the lowest estimate coming in at $312.50 million. ICU Medical reported sales of $370.12 million during the same quarter last year, which indicates a negative year-over-year growth rate of 15%. The firm is expected to issue its next quarterly earnings report after the market closes on Thursday, February 28th.
On average, analysts expect that ICU Medical will report full-year sales of $1.32 billion for the current financial year, with estimates ranging from $1.31 billion to $1.32 billion. For the next year, analysts expect that the firm will report sales of $1.33 billion, with estimates ranging from $1.32 billion to $1.33 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that follow ICU Medical.
A number of research analysts recently weighed in on ICUI shares. Zacks Investment Research raised ICU Medical from a “hold” rating to a “strong-buy” rating and set a $297.00 price objective on the stock in a research note on Thursday, November 1st. ValuEngine downgraded ICU Medical from a “buy” rating to a “hold” rating in a research report on Tuesday, November 6th. Finally, BidaskClub downgraded ICU Medical from a “buy” rating to a “hold” rating in a research report on Thursday, November 8th.
Shares of ICUI stock traded down $0.02 during trading on Thursday, reaching $252.99. The company had a trading volume of 71,676 shares, compared to its average volume of 153,334. ICU Medical has a one year low of $210.94 and a one year high of $321.70. The company has a market capitalization of $5.18 billion, a price-to-earnings ratio of 45.83 and a beta of 0.68.
In other ICU Medical news, Director Robert S. Swinney sold 1,500 shares of ICU Medical stock in a transaction that occurred on Monday, January 28th. The stock was sold at an average price of $242.19, for a total value of $363,285.00. Following the transaction, the director now directly owns 19,540 shares of the company’s stock, valued at approximately $4,732,392.60. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 12.50% of the company’s stock.
Several large investors have recently made changes to their positions in the company. Retirement Systems of Alabama grew its holdings in shares of ICU Medical by 0.4% during the 4th quarter. Retirement Systems of Alabama now owns 21,506 shares of the medical instruments supplier’s stock worth $4,938,000 after purchasing an additional 93 shares in the last quarter. Huntington National Bank boosted its stake in ICU Medical by 26.6% in the 4th quarter. Huntington National Bank now owns 443 shares of the medical instruments supplier’s stock valued at $102,000 after buying an additional 93 shares in the last quarter. Advisory Services Network LLC boosted its stake in ICU Medical by 475.0% in the 4th quarter. Advisory Services Network LLC now owns 115 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 95 shares in the last quarter. New York State Teachers Retirement System boosted its stake in ICU Medical by 0.4% in the 4th quarter. New York State Teachers Retirement System now owns 24,739 shares of the medical instruments supplier’s stock valued at $5,681,000 after buying an additional 100 shares in the last quarter. Finally, American International Group Inc. boosted its stake in ICU Medical by 0.4% in the 4th quarter. American International Group Inc. now owns 33,904 shares of the medical instruments supplier’s stock valued at $7,785,000 after buying an additional 126 shares in the last quarter. 80.28% of the stock is currently owned by institutional investors.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
See Also: Determine Your Level of Risk Tolerance
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.